Australian (ASX) Biotech Industry Analysis
UpdatedApr 25, 2024
DataAggregated Company Financials
Companies33
- 7D2.8%
- 3M-3.4%
- 1Y-8.0%
- YTDn/a
Over the last 7 days, the Biotech industry has dropped 4.2%, driven by a pullback from Race Oncology of 8.4%. However, the industry is down 10% over the past year. Earnings are forecast to grow by 16% annually.
Industry Valuation and Performance
Has the Australian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 25 Apr 2024 | AU$144.0b | AU$22.6b | AU$3.3b | 30.1x | 43.5x | 6.4x |
| Sat, 23 Mar 2024 | AU$143.7b | AU$22.5b | AU$3.3b | 29.4x | 43.5x | 6.4x |
| Mon, 19 Feb 2024 | AU$144.5b | AU$22.3b | AU$3.3b | 31x | 44x | 6.5x |
| Wed, 17 Jan 2024 | AU$144.9b | AU$20.8b | AU$2.8b | 33.3x | 52.6x | 7x |
| Fri, 15 Dec 2023 | AU$138.5b | AU$20.4b | AU$2.7b | 34.5x | 51.3x | 6.8x |
| Sun, 12 Nov 2023 | AU$128.5b | AU$21.5b | AU$2.9b | 30.2x | 44.6x | 6x |
| Tue, 10 Oct 2023 | AU$129.8b | AU$21.6b | AU$2.8b | 30x | 45.7x | 6x |
| Thu, 07 Sep 2023 | AU$138.6b | AU$21.5b | AU$2.8b | 33x | 49.2x | 6.4x |
| Sat, 05 Aug 2023 | AU$136.2b | AU$18.4b | AU$2.4b | 36.3x | 57.2x | 7.4x |
| Mon, 03 Jul 2023 | AU$142.7b | AU$18.1b | AU$2.3b | 37.8x | 61.2x | 7.9x |
| Wed, 31 May 2023 | AU$157.5b | AU$18.4b | AU$2.4b | 40.3x | 66.1x | 8.6x |
| Fri, 28 Apr 2023 | AU$155.5b | AU$18.2b | AU$2.3b | 41.8x | 66.3x | 8.6x |
| Sun, 26 Mar 2023 | AU$146.9b | AU$18.1b | AU$2.3b | 39.3x | 62.7x | 8.1x |
| Tue, 21 Feb 2023 | AU$151.8b | AU$17.2b | AU$2.3b | 51.3x | 66.7x | 8.8x |
| Thu, 19 Jan 2023 | AU$149.8b | AU$15.3b | AU$2.4b | 53.5x | 61.7x | 9.8x |
| Sat, 17 Dec 2022 | AU$149.0b | AU$16.1b | AU$2.6b | 46.8x | 58.1x | 9.3x |
| Mon, 14 Nov 2022 | AU$149.4b | AU$16.1b | AU$2.6b | 45.4x | 58.5x | 9.3x |
| Wed, 12 Oct 2022 | AU$144.0b | AU$17.1b | AU$2.8b | 40.6x | 52.2x | 8.4x |
| Fri, 09 Sep 2022 | AU$152.5b | AU$16.0b | AU$2.5b | 46.5x | 59.8x | 9.5x |
| Sun, 07 Aug 2022 | AU$151.3b | AU$15.6b | AU$2.8b | 41.4x | 53.6x | 9.7x |
| Tue, 05 Jul 2022 | AU$138.8b | AU$15.9b | AU$2.9b | 35.6x | 48.3x | 8.7x |
| Thu, 02 Jun 2022 | AU$138.4b | AU$15.1b | AU$2.7b | 36.5x | 51.2x | 9.2x |
| Sat, 30 Apr 2022 | AU$138.6b | AU$15.2b | AU$2.8b | 37.1x | 50.1x | 9.1x |
| Mon, 28 Mar 2022 | AU$135.1b | AU$14.3b | AU$2.6b | 39.4x | 52.1x | 9.4x |
| Wed, 23 Feb 2022 | AU$136.0b | AU$15.0b | AU$2.7b | n/a | 50.5x | 9.1x |
| Fri, 21 Jan 2022 | AU$141.0b | AU$14.5b | AU$2.8b | 39.5x | 51.1x | 9.7x |
| Sun, 19 Dec 2021 | AU$142.1b | AU$14.6b | AU$2.8b | 39.3x | 51x | 9.7x |
| Tue, 16 Nov 2021 | AU$154.5b | AU$14.3b | AU$2.7b | 43.5x | 57.1x | 10.8x |
| Thu, 14 Oct 2021 | AU$145.7b | AU$14.2b | AU$2.7b | 41.5x | 54.3x | 10.2x |
| Sat, 11 Sep 2021 | AU$150.1b | AU$14.0b | AU$2.6b | 43.5x | 57.2x | 10.7x |
| Mon, 09 Aug 2021 | AU$145.7b | AU$14.0b | AU$2.6b | 42.7x | 55.5x | 10.4x |
| Sun, 02 May 2021 | AU$132.5b | AU$13.5b | AU$2.8b | 37.3x | 46.8x | 9.8x |
Price to Earnings Ratio
46.8x
Current Industry PE
- Investors are pessimistic on the Australian Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 41.3x which is lower than its 3-year average PE of 54.0x.
- The 3-year average PS ratio of 8.7x is higher than the industry's current PS ratio of 6.1x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have grown 5.9% per year over the last three years.
- Revenues for these companies have grown 19% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Comparison
How does Australian Biotech compare with similar industries?
| AU Market | 0.91% | |
| Healthcare | 2.54% | |
| Biotech | 2.78% | |
| Biotech | 2.78% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CSL CSL | AU$278.45 | 2.1% +AU$2.8b | -8.9% | PE35.4x | |
| TLX Telix Pharmaceuticals | AU$14.88 | 18.7% +AU$773.3m | 43.2% | PE943.6x | |
| MSB Mesoblast | AU$0.92 | 22.0% +AU$188.3m | 4.6% | PS90.9x | |
| IMM Immutep | AU$0.45 | 28.6% +AU$118.9m | 73.1% | PS136.1x | |
| DXB Dimerix | AU$0.34 | 17.5% +AU$27.5m | 249.0% | PS20.2x |